Cargando…

The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study

BACKGROUND: Trimethylamine N-oxide (TMAO), a metabolite from red meat and fish consumption, plays a role in promoting cardiovascular events. However, data regarding TMAO and its impact on clinical outcomes are inconclusive, possibly due to its undetermined dietary source. OBJECTIVES: We hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Lu, Massy, Ziad A, Stenvinkel, Peter, Chesnaye, Nicholas C, Larabi, Islam Amine, Alvarez, Jean Claude, Caskey, Fergus J, Torino, Claudia, Porto, Gaetana, Szymczak, Maciej, Krajewska, Magdalena, Drechsler, Christiane, Wanner, Christoph, Jager, Kitty J, Dekker, Friedo W, Evenepoel, Pieter, Evans, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Research Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761748/ https://www.ncbi.nlm.nih.gov/pubmed/36166845 http://dx.doi.org/10.1093/ajcn/nqac278

Ejemplares similares

The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease
por: Massy, Ziad A, et al.
Publicado: (2021)

Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Renal function decline in older men and women with advanced chronic kidney disease—results from the EQUAL study
por: Chesnaye, Nicholas C, et al.
Publicado: (2020)

Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UK
por: Gates, Emer, et al.
Publicado: (2022)

Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study
por: Janmaat, Cynthia J, et al.
Publicado: (2020)

The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease
por: Astley, Megan, et al.
Publicado: (2023)

Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’
por: Eveleens Maarse, Boukje C, et al.
Publicado: (2022)

Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study
por: Eveleens Maarse, Boukje C, et al.
Publicado: (2021)

Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients
por: Ramspek, Chava L., et al.
Publicado: (2022)

Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study
por: Fu, Edouard L, et al.
Publicado: (2021)

CMPF: Class-switching minimized pathfinding in metabolic networks
por: Lim, Kevin, et al.
Publicado: (2012)

CMPF Does Not Associate with Impaired Glucose Metabolism in Individuals with Features of Metabolic Syndrome
por: Lankinen, Maria A., et al.
Publicado: (2015)

Where to look for the most frequent biases?
por: Jager, Kitty J., et al.
Publicado: (2020)

Points of attention when conducting etiological research
por: Stel, Vianda S., et al.
Publicado: (2021)

An introduction to joint models—applications in nephrology
por: Chesnaye, Nicholas C, et al.
Publicado: (2020)

Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
por: Chesnaye, Nicholas C., et al.
Publicado: (2019)

An introduction to inverse probability of treatment weighting in observational research
por: Chesnaye, Nicholas C, et al.
Publicado: (2021)

Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers
por: Fabresse, Nicolas, et al.
Publicado: (2023)

CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis
por: Prentice, Kacey J., et al.
Publicado: (2017)

Changes in clinical indicators related to the transition from dialysis to kidney transplantation—data from the ERA-EDTA Registry
por: Tantiyavarong, Pichaya, et al.
Publicado: (2019)

Predicting mortality after start of long-term dialysis–International validation of one- and two-year prediction models
por: Haapio, Mikko, et al.
Publicado: (2023)

Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?
por: Luce, Mathilde, et al.
Publicado: (2018)

The association between parathyroid hormone and mortality in dialysis patients is modified by wasting
por: Drechsler, Christiane, et al.
Publicado: (2009)

TMAO: a potential mediator of clopidogrel resistance
por: Ma, Ruisong, et al.
Publicado: (2021)

Trimethylamine N-oxide (TMAO) in human health
por: Gatarek, Paulina, et al.
Publicado: (2021)

A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020)

Increased serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with glucose metabolism in Chinese pregnant women
por: Yi, J., et al.
Publicado: (2017)

A new methodological series in CKJ: from basic-level methodology to artificial intelligence in medicine
por: Zoccali, Carmine, et al.
Publicado: (2023)

Work status and work ability of patients receiving kidney replacement therapy: results from a European survey
por: de Jong, Rianne W, et al.
Publicado: (2021)

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
por: Chen, Ming-liang, et al.
Publicado: (2016)

Uremic Toxins and Vascular Calcification–Missing the Forest for All the Trees
por: Rapp, Nikolas, et al.
Publicado: (2020)

Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population
por: Zhang, Shan, et al.
Publicado: (2017)

Background Diet Influences TMAO Concentrations Associated with Red Meat Intake without Influencing Apparent Hepatic TMAO-Related Activity in a Porcine Model
por: Thøgersen, Rebekka, et al.
Publicado: (2020)

Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients
por: Hai, Xin, et al.
Publicado: (2015)

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2017)

DMSO and TMAO—Differences in Interactions in Aqueous Solutions of the K-Peptide
por: Godlewska, Julia, et al.
Publicado: (2022)

3-Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) induces cell death through ferroptosis and acts as a trigger of apoptosis in kidney cells
por: Park, Jung Sun, et al.
Publicado: (2023)

Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems
por: Blankestijn, Peter J, et al.
Publicado: (2011)

The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?
por: Agarwal, Rajiv, et al.
Publicado: (2011)

Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease
por: London, Gerard, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_u6lej3o4kr6petlndfevovdu13